13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q4 2023 · Filed November 8, 2023 · Accession 0001213900-23-084732
Total Value
$912.8M
Positions
53
Other Managers
0
Confidential Omitted
No
Holdings (53)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Genetron Holdings Ltd | 37186H100 | 8,124,174 | $104.6M | 11.46% |
| 2 | Soleno Therapeutics Inc | SLNO | 3,203,093 | $94.5M | 10.36% |
| 3 | Harmony Biosciences Holdings Inc | HRMY | 2,606,247 | $85.4M | 9.36% |
| 4 | Verona Pharma PLC | 925050106 | 4,249,918 | $69.3M | 7.59% |
| 5 | Avadel Pharmaceuticals PLC | 05337M104 | 4,096,428 | $42.2M | 4.62% |
| 6 | Tarsus Pharmaceuticals Inc | TARS | 2,262,200 | $40.2M | 4.40% |
| 7 | Sinovac Biotech Ltd. | SVA | 5,900,000 | $38.2M | 4.18% |
| 8 | Geron Corp | GERN | 16,524,634 | $35.0M | 3.84% |
| 9 | Terns Pharmaceuticals Inc | TERN | 6,657,992 | $33.5M | 3.67% |
| 10 | Gracell Biotechnologies Inc | 38406L103 | 10,881,144 | $31.3M | 3.43% |
| 11 | Viridian Therapeutics Inc | VRDN | 1,678,207 | $25.7M | 2.82% |
| 12 | Olema Pharmaceuticals Inc | OLMA | 1,873,704 | $23.1M | 2.54% |
| 13 | Cogent Biosciences Inc | COGT | 2,244,941 | $21.9M | 2.40% |
| 14 | ALX Oncology Holdings Inc | ALXO | 4,220,048 | $20.3M | 2.22% |
| 15 | Arcellx Inc. | ACLX | 503,565 | $18.1M | 1.98% |
| 16 | Ventyx Biosciences Inc | 92332V107 | 422,075 | $14.7M | 1.61% |
| 17 | Rayzebio Inc | 75525N107 | 633,576 | $14.1M | 1.54% |
| 18 | Icosavax, Inc. | 45114M109 | 1,704,568 | $13.2M | 1.45% |
| 19 | Astria Therapeutics Inc | 04635X102 | 1,681,199 | $12.5M | 1.37% |
| 20 | Verastem Inc | VSTM | 1,538,461 | $12.5M | 1.37% |
| 21 | Compass Pathway PLC | CMPS | 1,608,000 | $11.9M | 1.30% |
| 22 | Zai Lab Ltd ADR | ZLAB | 454,606 | $11.1M | 1.21% |
| 23 | Alpine Immune Sciences Inc | 02083G100 | 914,913 | $10.5M | 1.15% |
| 24 | Crinetics Pharmaceuticals Inc | CRNX | 350,000 | $10.4M | 1.14% |
| 25 | Dyne Therapeutics Inc | DYN | 1,035,136 | $9.3M | 1.02% |
| 26 | IO Biotech Inc | IOBT | 6,173,439 | $8.7M | 0.95% |
| 27 | Apogee Therapeutics Inc | APGE | 400,000 | $8.5M | 0.93% |
| 28 | KalVista Pharmaceuticals Inc. | KALV | 856,008 | $8.2M | 0.90% |
| 29 | Delcath Systems, Inc. | DCTH | 1,855,191 | $7.5M | 0.82% |
| 30 | Savara Inc | SVRA | 1,913,349 | $7.2M | 0.79% |
| 31 | Compass Therapeutics Inc | CMPX | 3,556,023 | $7.0M | 0.77% |
| 32 | Allakos Inc | 01671P100 | 2,988,000 | $6.8M | 0.74% |
| 33 | Aadi Bioscience Inc | WHWK | 509,572 | $6.5M | 0.71% |
| 34 | Aclaris Therapeutics, Inc. | ACRS | 898,631 | $6.2M | 0.67% |
| 35 | Instil Bio Inc | TIL | 12,486,787 | $5.3M | 0.59% |
| 36 | Oric Pharmaceuticals Inc | ORIC | 777,944 | $4.7M | 0.52% |
| 37 | Bolt Therapeutics Inc | BOLT | 3,871,291 | $4.0M | 0.44% |
| 38 | Arrowhead Pharmaceuticals Inc | ARWR | 137,411 | $3.7M | 0.40% |
| 39 | DBV Technologies SA | DBVTF | 2,708,875 | $3.7M | 0.40% |
| 40 | Sera Prognostics Inc | SERA | 1,856,011 | $3.5M | 0.38% |
| 41 | Unicycive Therapeutics | UNCY | 3,470,152 | $3.0M | 0.33% |
| 42 | Iovance Biotherapeutics Inc | IOVA | 655,057 | $3.0M | 0.33% |
| 43 | Aligos Therapeutics Inc | ALGS | 3,547,030 | $2.6M | 0.29% |
| 44 | Fulcrum Therapeutics Inc | FULC | 520,000 | $2.3M | 0.25% |
| 45 | Clene Inc | CLNN | 2,645,338 | $1.4M | 0.15% |
| 46 | Impel NeuroPharma Inc | 45258K109 | 2,884,789 | $1.2M | 0.14% |
| 47 | Aslan Pharmaceuticals Ltd | 04522R101 | 568,182 | $1.1M | 0.12% |
| 48 | BioAtla Inc | BCAB | 534,181 | $908,108 | 0.10% |
| 49 | Codexis, Inc | CDXS | 388,144 | $733,592 | 0.08% |
| 50 | Rezolute Inc | RZLT | 484,439 | $639,459 | 0.07% |
| 51 | Amyris, Inc | 03236M200 | 7,750,828 | $465,050 | 0.05% |
| 52 | Homology Medicines, Inc. | 438083107 | 370,068 | $432,980 | 0.05% |
| 53 | Precision Biosciences Inc | DTIL | 140,255 | $47,869 | 0.01% |